The Trump administration has effectively stalled vital funding for biomedical research through restrictive measures preventing public notice of grant review meetings. This has led to canceled review panels and funding gaps, impacting research on critical diseases like cancer and addiction. Major institutions, including Columbia University and MIT, have reacted by freezing hiring and spending or reassessing admissions. As the National Institutes of Health grapple with indefinite delays, scientists are expressing concerns over a growing crisis in American biomedical research, particularly amid attempts to bypass a federal judge's order to release funds.
The blockage stems from an order forbidding health officials from giving public notice of upcoming grant review meetings, creating a pause in the N.I.H.'s funding machinery.
Scores of grant review panels were canceled, resulting in a crisis in biomedical research funding that has affected hiring and spending across major universities.
Collection
[
|
...
]